| 2.97 0.05 (1.71%) | 10-24 14:54 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 3.67 | 1-year : | 3.97 |
| Resists | First : | 3.14 | Second : | 3.4 |
| Pivot price | 3.01  |
|||
| Supports | First : | 2.73 | Second : | 2.27 |
| MAs | MA(5) : | 2.92 |
MA(20) : | 3.01 |
| MA(100) : | 2.84 |
MA(250) : | 1.58 |
|
| MACD | MACD : | -0.1 |
Signal : | 0 |
| %K %D | K(14,3) : | 23.4 |
D(3) : | 20.4 |
| RSI | RSI(14): 50.5 |
|||
| 52-week | High : | 5.48 | Low : | 0.4 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.[ ABVC ] has closed above bottom band by 44.2%. Bollinger Bands are 49.7% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 30 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 2.94 - 2.96 | 2.96 - 2.98 |
| Low: | 2.78 - 2.8 | 2.8 - 2.82 |
| Close: | 2.89 - 2.92 | 2.92 - 2.95 |
Fri, 24 Oct 2025
Is ABVC BioPharma Inc. stock a buy before product launches - 2025 Big Picture & Technical Confirmation Alerts - newser.com
Fri, 24 Oct 2025
Will ABVC BioPharma Inc. price bounce be sustainable - 2025 Market Trends & Accurate Buy Signal Alerts - newser.com
Fri, 24 Oct 2025
Why analysts upgrade ABVC BioPharma Inc. stock - Rate Cut & Free Fast Gain Swing Trade Alerts - newser.com
Thu, 23 Oct 2025
How institutional ownership impacts ABVC BioPharma Inc. stock - Portfolio Update Summary & AI Forecasted Stock Moves - newser.com
Thu, 23 Oct 2025
Will earnings trigger a reversal in ABVC BioPharma Inc. - Quarterly Trade Summary & Fast Entry Momentum Trade Alerts - newser.com
Thu, 23 Oct 2025
How ABVC BioPharma Inc. stock performs after earnings - Insider Selling & Reliable Breakout Forecasts - newser.com
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
NASDAQ
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 0 (M) |
| Shares Float | 24 (M) |
| Held by Insiders | 2.005e+007 (%) |
| Held by Institutions | 11.7 (%) |
| Shares Short | 701 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | -3.96e+006 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0 |
| Profit Margin | 0 % |
| Operating Margin | -1 % |
| Return on Assets (ttm) | 21 % |
| Return on Equity (ttm) | -16.2 % |
| Qtrly Rev. Growth | 391240 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | -175.57 |
| EBITDA (p.s.) | 1.30317e+006 |
| Qtrly Earnings Growth | -0.3 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | -2 (M) |
| PE Ratio | -0.01 |
| PEG Ratio | 0 |
| Price to Book value | 0 |
| Price to Sales | -0.02 |
| Price to Cash Flow | 2.42 |
| Dividend | 0 |
| Forward Dividend | 635560 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|